AstraZeneca pushes early screening for lung cancer

Rhodina Villanueva - The Philippine Star
AstraZeneca pushes early screening for lung cancer
In this file photo taken on July 21, 2020 a general view is pictured of the offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire.
Paul Ellis / AFP

MANILA, Philippines — A multinational biopharmaceutical company is investing in early screening to help reduce deaths from lung cancer.

“At AstraZeneca, we are advancing our commitment to increase lung cancer screening and timely diagnosis and bring treatment to earlier lung cancer settings,” Dr. Cyril Tolosa, medical affairs director of AstraZeneca Philippines, said in an interview.

“This includes thinking differently about the underlying biology of lung cancer, from early stages – where we aim to help patients live longer and cancer-free – to late stages, where we look to meaningfully extend survival,” Tolosa added.

At the same time, the company official cited the importance of collaboration in the scientific community to improve outcomes for patients.

“AstraZeneca collaborates with key stakeholders and decision-makers to ensure innovative solutions can reach patients, no matter where they live,” she said.

“By leveraging the latest technologies and insights, AstraZeneca is dedicated to providing new options for patients and clinicians that allow them the opportunity to achieve improved survival,” she added.

vuukle comment


  • Latest
  • Trending
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

or sign in with